Woodhouse: #AACR18 Fusion, CNVs, SNVs, indels. 40% of ctDNA is below 1% AF in NSCLC. Remon et al looked at EGFR T790M+ pts to Osimertinib

4:49pm April 15th 2018 via Hootsuite